ASCEND BY NTHRYS
Research Abroad Products

Virology Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 220 project topics
High-Throughput Viral Screening Platform with AI Prediction
A cloud-based SaaS platform that automates screening of compound libraries against multiple viral targets using robotic systems and machine learning algorithms. Enables pharmaceutical companies to reduce screening time by 70% and accelerate lead candidate identification, generating recurring license fees and per-sample processing revenue.
Antiviral Drug Discovery & Screening Services Click to view more details →
Real-Time Viral Mutation Tracking and Resistance Profiling Service
An integrated bioinformatics service that sequences and analyzes viral genomes to detect drug-resistant mutations in real-time, delivering actionable insights via API integration. Supports pharmaceutical clients in monitoring treatment efficacy and informs pipeline decisions, enabling subscription-based revenue from healthcare systems and research institutions.
Antiviral Drug Discovery & Screening Services Click to view more details →
Cell Culture Viral Infectivity Assay Kit and Workflow Automation
A proprietary standardized assay kit combined with automated liquid handling protocols for rapid measurement of viral titers and drug potency in cell culture systems. Delivers premium pricing through proprietary reagent licensing and workflow software subscriptions while reducing assay variability for consistent results.
Antiviral Drug Discovery & Screening Services Click to view more details →
Structure-Based Virtual Screening Engine for Antiviral Drug Design
A computational platform utilizing cryo-EM and X-ray crystal structure databases to perform ultra-large virtual screening against viral proteins, integrated with docking and scoring algorithms. Generates revenue through SaaS subscriptions, per-project consulting fees, and licensing agreements with biotech and pharma companies seeking rapid hit identification.
Antiviral Drug Discovery & Screening Services Click to view more details →
Broad-Spectrum Viral Panel Testing and Susceptibility Profiling Platform
A multiplex diagnostic platform capable of simultaneously testing compounds against a panel of related viral species and measuring antiviral susceptibility profiles in standardized format. Monetizes through clinical laboratory partnerships, pharmaceutical outsourcing contracts, and data analytics licensing for comparative efficacy studies.
Antiviral Drug Discovery & Screening Services Click to view more details →
Machine Learning Drug Repurposing Platform for Viral Targets
A proprietary AI platform that analyzes historical screening data and published literature to identify FDA-approved drug candidates for repositioning against emerging viral pathogens. Provides rapid go-to-market opportunities for sponsors through computational predictions, generating revenue via licensing deals and milestone-based partnerships with pharmaceutical companies.
Antiviral Drug Discovery & Screening Services Click to view more details →
Tissue-Specific 3D Organoid Models for Antiviral Drug Efficacy Testing
A custom bioengineered service providing human-relevant 3D organoid models infected with target viruses for testing compound efficacy in physiologically realistic microenvironments. Captures premium service fees from pharmaceutical sponsors seeking superior predictivity over 2D cultures, reducing late-stage failure rates and supporting higher valuations in clinical development.
Antiviral Drug Discovery & Screening Services Click to view more details →
Viral Enzyme Kinetics and Mechanism of Action Analysis Service
A specialized analytical service employing surface plasmon resonance, isothermal titration calorimetry, and enzyme kinetics assays to characterize drug-target interactions and binding mechanisms for antiviral candidates. Enables differentiation of lead compounds through detailed MOA data, commanding premium pricing from sponsors seeking competitive advantages and patent-enabling information.
Antiviral Drug Discovery & Screening Services Click to view more details →
Regulatory-Compliant Antiviral Screening Data Management and Reporting System
An enterprise software solution designed specifically for GMP-compliant documentation, archival, and regulatory-ready reporting of antiviral screening assay results and chain-of-custody records. Streamlines IND and NDA submissions while reducing compliance risk, generating steady recurring revenue through software licensing, validation services, and regulatory consulting.
Antiviral Drug Discovery & Screening Services Click to view more details →
Next-Generation Sequencing-Based Viral Fitness and Escapability Prediction Tool
A bioinformatics tool that leverages deep sequencing of viral populations exposed to antiviral compounds to predict resistance development and viral escapability rates with high precision. Monetizes through research collaboration fees, subscription access for biotech clients, and data licensing to pharmaceutical companies developing combination therapy strategies.
Antiviral Drug Discovery & Screening Services Click to view more details →
Real-time Viral Load Quantification SaaS Platform
A cloud-based software platform that integrates PCR and sequencing data to provide instant viral load measurements across multiple pathogen types in clinical and research settings. This enables laboratories to charge premium fees for rapid turnaround diagnostics while reducing operational costs through automated data processing and standardized reporting workflows.
Viral Diagnostic Platform Commercial Development Click to view more details →
Multiplexed Pathogen Detection Cartridge System
A commercial point-of-care diagnostic cartridge that simultaneously detects 20+ viral pathogens from a single sample in under 30 minutes using microfluidic technology. This creates recurring revenue through consumable cartridge sales while capturing high-margin urgent care and hospital laboratory markets willing to pay premium prices for comprehensive pathogen profiling.
Viral Diagnostic Platform Commercial Development Click to view more details →